Il Dong Pharmaceutical Co., Ltd. logo

Il Dong Pharmaceutical Co., Ltd. (249420)

Market Closed
12 Jun, 06:30
KRX SM KRX SM
19,270. 00
+700
+3.7695%
910.58B Market Cap
- P/E Ratio
380.95% Div Yield
150,960 Volume
0 Eps
18,570
Previous Close
Add Transaction
Day Range
18,900 19,690
Year Range
12,070 45,050
Want to track 249420 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

249420 closed today higher at ₩19,270, an increase of 3.7695% from yesterday's close, completing a monthly decrease of -15.4825% or -₩3,530. Over the past 12 months, 249420 stock lost -49.9481%.
249420 is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2025, exceeded the consensus estimates by 36.7868%. On average, the company has surpassed earnings expectations by 18.3934%, based on the last three reports.
Il Dong Pharmaceutical Co., Ltd. has completed 4 stock splits, with the recent split occurring on Mar 05, 2020.
The company's stock is traded on one exchange.

249420 Chart

People also search for

Hyundai Motor Co.
607,000
+1.675%
Hyundai Motor Co. Ltd.
233,000
+4.0179%
Hyundai Motor Co. Ltd. Preferred
241,500
+2.9851%
Hyundai Motor Co., Ltd. Preferred
241,000
+2.3355%
Kia Corporation
166,800
+6.9231%

Il Dong Pharmaceutical Co., Ltd. (249420) FAQ

What is the stock price today?

The current price is ₩19,270.00.

On which exchange is it traded?

Il Dong Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 249420.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 380.95%.

What is its market cap?

As of today, the market cap is 910.58B.

Has Il Dong Pharmaceutical Co., Ltd. ever had a stock split?

Il Dong Pharmaceutical Co., Ltd. had 4 splits and the recent split was on Mar 05, 2020.

Il Dong Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Yun Paul Woongsup CEO
KRX SM Exchange
KR7249420001 ISIN
South Korea Country
1,061 Employees
30 Mar 2026 Last Dividend
27 Dec 2018 Last Split
- IPO Date

Overview

Ildong Pharmaceutical Co., Ltd., established in 1941, stands as a significant player in the pharmaceutical industry within South Korea. This company focuses on the development, manufacture, and sale of a wide range of pharmaceutical products. It has built a reputation for providing diverse healthcare solutions, including active lactic acid bacterial and anti-diarrheal agents, along with a variety of other pharmaceuticals aimed at treating numerous health conditions. Ildong Pharmaceutical Co., Ltd. not only caters to the domestic market but has also expanded its reach internationally, exporting products to approximately 20 countries worldwide. The company has entered a strategic collaboration with Evotec SE to further enrich its product development capabilities through the INDiGO platform, highlighting its commitment to innovation and global pharmaceutical advancement. The headquarters of Ildong Pharmaceutical Co., Ltd. is located in Seoul, South Korea.

Products and Services

Ildong Pharmaceutical Co., Ltd. offers a broad portfolio of products and services across various therapeutic areas, catering to a wide range of healthcare needs. Some of their offerings include:

  • Active Lactic Acid Bacterial and Anti-Diarrheal Agents: These products focus on improving gastrointestinal health and treating conditions such as diarrhea.
  • Antibiotics, Antifungal, and Antiviral Products: A suite of medications aimed at combating bacterial, fungal, and viral infections, addressing the essential need for infection control.
  • Anti-Histamine Drugs: These are designed to alleviate allergies by preventing the effects of histamine, a substance in the body that can cause allergic reactions.
  • Antineoplastic Agents: Crucial in the fight against cancer, these drugs are used to halt the growth and spread of cancer cells.
  • NSAIDs and Analgesics: Nonsteroidal anti-inflammatory drugs and pain relievers to manage pain and inflammation for various conditions.
  • Vitamins, Minerals, and Nutrients: Supplements to support overall health and well-being by providing essential nutrients.
  • Cardiovascular and Central Nervous System Drugs: Medications aimed at managing heart diseases and disorders affecting the central nervous system.
  • Medical Devices: This includes items for scar treatment and other devices aimed at improving patient care.
  • Health Foods and Cosmetics: Beyond pharmaceuticals, the company also ventures into health foods and cosmetics, endorsing a broader approach to health and wellness.
  • Contract Manufacturing and Licensing Management: Ildong Pharmaceutical leverages its extensive experience in drug development and manufacturing by offering these services to other companies, facilitating the broader availability of healthcare solutions.

Contact Information

Address: 2, Baumoe-ro 27-gil
Phone: 82 2 526 3114